{"transactions":[{"id":1066715,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":76531,"kind":"person","name":"Blaustein Robert","position":1,"cik":"0002053149","reported_name":"Blaustein Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-08-14T19:44:14.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":105000,"derivative":{"exercise_price":13.39,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001562180-25-005800","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2053149/000156218025005800/primarydocument.xml","form_type":"4"}},{"id":1066714,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":76531,"kind":"person","name":"Blaustein Robert","position":1,"cik":"0002053149","reported_name":"Blaustein Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T19:44:14.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":17500,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001562180-25-005800","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053149/000156218025005800/primarydocument.xml","form_type":"4"}},{"id":1296596,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":76531,"kind":"person","name":"Blaustein Robert","position":1,"cik":"0002053149","reported_name":"Blaustein Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-23T19:56:52.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option become vested and exercisable on January 21, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":160000,"derivative":{"exercise_price":27.39,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001562180-25-000497","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2053149/000156218025000497/primarydocument.xml","form_type":"4"}},{"id":1296595,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":76531,"kind":"person","name":"Blaustein Robert","position":1,"cik":"0002053149","reported_name":"Blaustein Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T19:56:52.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on January 21, 2026."}],"balance_after":30000,"derivative":{"exercise_price":0,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-25-000497","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053149/000156218025000497/primarydocument.xml","form_type":"4"}}]}